Repair after myocardial infarction, between fantasy and reality: the role of chemokines - PubMed
- ️Sat Jan 01 2011
Review
. 2011 Nov 29;58(23):2357-62.
doi: 10.1016/j.jacc.2011.08.034.
Affiliations
- PMID: 22115639
- DOI: 10.1016/j.jacc.2011.08.034
Free article
Review
Repair after myocardial infarction, between fantasy and reality: the role of chemokines
Elisa A Liehn et al. J Am Coll Cardiol. 2011.
Free article
Abstract
Despite considerable progress over the last decades, acute myocardial infarction continues to remain the major cause of morbidity and mortality worldwide. The present therapies include only cause-dependent interventions, which are not able to reduce myocardial necrosis and optimize cardiac repair following infarction. This review highlights the cellular and molecular processes after myocardial injury and focuses on chemokines, the main modulators of the inflammatory and reparatory events, as the most valuable drug targets.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
SDF-1α as a therapeutic stem cell homing factor in myocardial infarction.
Ghadge SK, Mühlstedt S, Ozcelik C, Bader M. Ghadge SK, et al. Pharmacol Ther. 2011 Jan;129(1):97-108. doi: 10.1016/j.pharmthera.2010.09.011. Epub 2010 Oct 20. Pharmacol Ther. 2011. PMID: 20965212 Review.
-
Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction.
Vilahur G, Juan-Babot O, Peña E, Oñate B, Casaní L, Badimon L. Vilahur G, et al. J Mol Cell Cardiol. 2011 Mar;50(3):522-33. doi: 10.1016/j.yjmcc.2010.12.021. Epub 2011 Jan 8. J Mol Cell Cardiol. 2011. PMID: 21219908
-
Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy.
Wang F, Guan J. Wang F, et al. Adv Drug Deliv Rev. 2010 Jun 15;62(7-8):784-97. doi: 10.1016/j.addr.2010.03.001. Epub 2010 Mar 6. Adv Drug Deliv Rev. 2010. PMID: 20214939 Review.
-
Signaling factors in stem cell-mediated repair of infarcted myocardium.
Vandervelde S, van Luyn MJ, Tio RA, Harmsen MC. Vandervelde S, et al. J Mol Cell Cardiol. 2005 Aug;39(2):363-76. doi: 10.1016/j.yjmcc.2005.05.012. J Mol Cell Cardiol. 2005. PMID: 15992820 Review.
-
Kawaguchi M, Takahashi M, Hata T, Kashima Y, Usui F, Morimoto H, Izawa A, Takahashi Y, Masumoto J, Koyama J, Hongo M, Noda T, Nakayama J, Sagara J, Taniguchi S, Ikeda U. Kawaguchi M, et al. Circulation. 2011 Feb 15;123(6):594-604. doi: 10.1161/CIRCULATIONAHA.110.982777. Epub 2011 Jan 31. Circulation. 2011. PMID: 21282498
Cited by
-
Ma W, Li X, Gao C, Gao Y, Liu Y, Kang S, Pan J. Ma W, et al. Diagnostics (Basel). 2022 Nov 14;12(11):2780. doi: 10.3390/diagnostics12112780. Diagnostics (Basel). 2022. PMID: 36428840 Free PMC article.
-
Vitamin D inflammatory cytokines and coronary events: a comprehensive review.
Arnson Y, Itzhaky D, Mosseri M, Barak V, Tzur B, Agmon-Levin N, Amital H. Arnson Y, et al. Clin Rev Allergy Immunol. 2013 Oct;45(2):236-47. doi: 10.1007/s12016-013-8356-0. Clin Rev Allergy Immunol. 2013. PMID: 23314982 Clinical Trial.
-
Prostaglandin E2 in remote control of myocardial remodeling.
Sun H, Wang Y. Sun H, et al. Circulation. 2012 Jun 12;125(23):2818-20. doi: 10.1161/CIRCULATIONAHA.112.110726. Epub 2012 May 15. Circulation. 2012. PMID: 22589382 Free PMC article. No abstract available.
-
Infarct in the Heart: What's MMP-9 Got to Do with It?
Becirovic-Agic M, Chalise U, Daseke MJ 2nd, Konfrst S, Salomon JD, Mishra PK, Lindsey ML. Becirovic-Agic M, et al. Biomolecules. 2021 Mar 25;11(4):491. doi: 10.3390/biom11040491. Biomolecules. 2021. PMID: 33805901 Free PMC article. Review.
-
Gong S, Zhai M, Shi J, Yu G, Lei Z, Shi Y, Zeng Y, Ju P, Yang N, Zhang Z, Zhang D, Zhuang J, Yu Q, Zhang X, Jian W, Wang W, Peng W. Gong S, et al. Cell Death Differ. 2024 Feb;31(2):239-253. doi: 10.1038/s41418-023-01252-8. Epub 2024 Jan 5. Cell Death Differ. 2024. PMID: 38182899 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical